setmelanotide vs semaglutide What's New in Obesity Treatment? Setmelanotide - an overview |

Description

Inflammation promotes insulin resistance and fatty liver

Novo Nordisk and Eli Lilly have been scrutinized over prices for the popular class of diabetes and obesity medications known as GLP-1, or or glucagon-like peptide-1, drugs

The US obesity rate, after decades of unstoppable growth, has at last started to plateau, but at a level that continues to lead the developed world

Signs and symptoms of low blood sugar may include : dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery dehydration leading to kidney problems

Low blood sugar (hypoglycemia) is another concern, particularly if you are also taking diabetes medications like insulin or sulfonylureas alongside semaglutide